Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 20;7(51):85058-85062.
doi: 10.18632/oncotarget.13187.

Expressions of miR-30c and let-7a are inversely correlated with HMGA2 expression in squamous cell carcinoma of the vulva

Affiliations

Expressions of miR-30c and let-7a are inversely correlated with HMGA2 expression in squamous cell carcinoma of the vulva

Antonio Agostini et al. Oncotarget. .

Abstract

Malignant tumors of the vulva, most of them squamous cell carcinomas, account for only 5% of cancers of the female genital tract. Though little is known about the genetic features of these tumors, the Fragile Histidine Triad (FHIT) and High Mobility Group AT-hook 2 (HMGA2) genes were found deregulated. We wanted to gain more knowledge about the expression of HMGA2-related miRNAs such as miR-30c and let-7a, and whether a correlation exists between the expression of FHIT and HMGA2, in this tumor type. An inverse correlation was found in-as-much as HMGA2 was highly expressed (mean fold change 8.8) whereas miR30c and let-7a were both downregulated (mean fold change -3.9 and -2.3, respectively). The consistent overexpression of HMGA2 found in all tumors adds to the likelihood that this gene is of importance in SCC pathogenesis. Moreover, we came to the conclusion that miRNAs may be the cause of the deregulation of HMGA2. Our results also show that SCC of the vulva presents a characteristic molecular pattern with FHIT being downregulated whereas HMGA2 is upregulated.

Keywords: FHIT; HMGA2; let-7a; miR-30c.

PubMed Disclaimer

Conflict of interest statement

COMPETING INTEREST

The authors have no competing interest to disclose.

Figures

Figure 1
Figure 1. Expression profile of the 10 SCC of the vulva
A. Relative normalized expression of HMGA2 and LIN28A. B. Relative normalized expression of miR-30c and let-7a.

References

    1. Wilkinson E. Premalignant and Malignant Tumors of the Vulva. In: Kurman R, Ellenson L, Ronnett B, editors. Blausteins Pathology of the Female Genital Tract; Springer US: 2011. pp. 55–103.
    1. Micci F, Panagopoulos I, Haugom L, Dahlback HS, Pretorius ME, Davidson B, Abeler VM, Trope CG, Danielsen HE, Heim S. Genomic aberration patterns and expression profiles of squamous cell carcinomas of the vulva. Genes ChromosomesCancer. 2013;52:551–563. - PubMed
    1. Teixeira MR, Kristensen GB, Abeler VM, Heim S. Karyotypic findings in tumors of the vulva and vagina. Cancer Genet Cytogenet. 1999;111:87–91. - PubMed
    1. Micci F, Teixeira MR, Scheistroen M, Abeler VM, Heim S. Cytogenetic characterization of tumors of the vulva and vagina. Genes ChromosomesCancer. 2003;38:137–148. - PubMed
    1. Worsham MJ, Van Dyke DL, Grenman SE, Grenman R, Hopkins MP, Roberts JA, Gasser KM, Schwartz DR, Carey TE. Consistent chromosome abnormalities in squamous cell carcinoma of the vulva. Genes ChromosomesCancer. 1991;3:420–432. - PubMed

MeSH terms